Role of the SIK2–p35–PJA2 complex in pancreatic β-cell functional compensation

[1]  A. Dobrzyń,et al.  Islet β-cell failure in type 2 diabetes--Within the network of toxic lipids. , 2015, Biochemical and biophysical research communications.

[2]  J. Sanes,et al.  SAD-A kinase controls islet β-cell size and function as a mediator of mTORC1 signaling , 2013, Proceedings of the National Academy of Sciences.

[3]  R. Screaton,et al.  CRTC2 is required for β-cell function and proliferation. , 2013, Endocrinology.

[4]  R. Screaton,et al.  Role of AMPK in pancreatic beta cell function , 2013, Molecular and Cellular Endocrinology.

[5]  Rebecca E. Saunders,et al.  Salt-inducible kinases regulate growth through the Hippo signalling pathway in Drosophila , 2012, Nature Cell Biology.

[6]  Angela N. Brooks,et al.  Mapping the Hallmarks of Lung Adenocarcinoma with Massively Parallel Sequencing , 2012, Cell.

[7]  Amber L. Couzens,et al.  Mass spectrometry approaches to study mammalian kinase and phosphatase associated proteins. , 2012, Methods.

[8]  N. Ip,et al.  Cdk5: a multifaceted kinase in neurodegenerative diseases. , 2012, Trends in cell biology.

[9]  E. Oetjen.  Antidiabetic actions of a non–agonist PPARγ ligand blocking Cdk5–mediated phosphorylation , 2012 .

[10]  G. Aguilera,et al.  Salt-inducible kinase is involved in the regulation of corticotropin-releasing hormone transcription in hypothalamic neurons in rats. , 2012, Endocrinology.

[11]  L. Tsai,et al.  Cyclin-dependent kinases in brain development and disease. , 2011, Annual review of cell and developmental biology.

[12]  M. Prentki,et al.  Type 2 diabetes across generations: from pathophysiology to prevention and management , 2011, The Lancet.

[13]  Tadao Shibasaki,et al.  Dynamics of insulin secretion and the clinical implications for obesity and diabetes. , 2011, The Journal of clinical investigation.

[14]  John B. Thomas,et al.  A Hormone-Dependent Module Regulating Energy Balance , 2011, Cell.

[15]  L. Annunziato,et al.  Control of PKA stability and signalling by the RING ligase praja2 , 2011, Nature Cell Biology.

[16]  S. Sakoda,et al.  SIK2 Is a Key Regulator for Neuronal Survival after Ischemia via TORC1-CREB , 2011, Neuron.

[17]  Jongkyeong Chung,et al.  Drosophila Salt-inducible Kinase (SIK) Regulates Starvation Resistance through cAMP-response Element-binding Protein (CREB)-regulated Transcription Coactivator (CRTC)* , 2010, The Journal of Biological Chemistry.

[18]  K. Kitagawa,et al.  Downregulation of SIK2 expression promotes the melanogenic program in mice , 2010, Pigment cell & melanoma research.

[19]  J. Girard,et al.  Salt-inducible kinase 2 links transcriptional coactivator p300 phosphorylation to the prevention of ChREBP-dependent hepatic steatosis in mice. , 2010, The Journal of clinical investigation.

[20]  Failure of islet β‐cell compensation for insulin resistance causes type 2 diabetes: What causes non‐alcoholic fatty liver disease and non‐alcoholic steatohepatitis? , 2010, Journal of gastroenterology and hepatology.

[21]  Tony Pawson,et al.  ProHits: an integrated software platform for mass spectrometry-based interaction proteomics , 2010, Nature Biotechnology.

[22]  R. Bast,et al.  SIK2 is a centrosome kinase required for bipolar mitotic spindle formation that provides a potential target for therapy in ovarian cancer. , 2010, Cancer cell.

[23]  A. Rosenwald,et al.  Amplification at 11q23 targets protein kinase SIK2 in diffuse large B-cell lymphoma , 2010, Leukemia & lymphoma.

[24]  G. Rutter,et al.  LKB1 deletion with the RIP2.Cre transgene modifies pancreatic β-cell morphology and enhances insulin secretion in vivo , 2010, American journal of physiology. Endocrinology and metabolism.

[25]  M. Laakso,et al.  Impaired beta cell glucose sensitivity rather than inadequate compensation for insulin resistance is the dominant defect in glucose intolerance , 2010, Diabetologia.

[26]  M. Lombès,et al.  Involvement of SIK2/TORC2 signaling cascade in the regulation of insulin-induced PGC-1alpha and UCP-1 gene expression in brown adipocytes. , 2009, American journal of physiology. Endocrinology and metabolism.

[27]  J. Vandekerckhove,et al.  The atypical kinase Cdk5 is activated by insulin, regulates the association between GLUT4 and E-Syt1, and modulates glucose transport in 3T3-L1 adipocytes , 2009, Proceedings of the National Academy of Sciences.

[28]  R. Screaton,et al.  Glucose controls CREB activity in islet cells via regulated phosphorylation of TORC2 , 2008, Proceedings of the National Academy of Sciences.

[29]  J. Florez.  Newly identified loci highlight beta cell dysfunction as a key cause of type 2 diabetes: Where are the insulin resistance genes? , 2008, Diabetologia.

[30]  John B. Thomas,et al.  The insulin-regulated CREB coactivator TORC promotes stress resistance in Drosophila. , 2008, Cell metabolism.

[31]  L. Brennan,et al.  Amino acid metabolism, insulin secretion and diabetes. , 2007, Biochemical Society transactions.

[32]  J. Yates,et al.  Insulin modulates gluconeogenesis by inhibition of the coactivator TORC2. , 2007, Nature.

[33]  M. Prentki,et al.  Islet beta cell failure in type 2 diabetes. , 2006, The Journal of clinical investigation.

[34]  K. Mikoshiba,et al.  Cdk5-dependent regulation of glucose-stimulated insulin secretion , 2005, Nature Medicine.

[35]  J. Yates,et al.  The CREB Coactivator TORC2 Functions as a Calcium- and cAMP-Sensitive Coincidence Detector , 2004, Cell.

[36]  John Calvin Reed,et al.  cAMP promotes pancreatic β-cell survival via CREB-mediated induction of IRS2 , 2003 .

[37]  S. Kahn,et al.  The relative contributions of insulin resistance and beta-cell dysfunction to the pathophysiology of Type 2 diabetes , 2003, Diabetologia.

[38]  Xueying Lin,et al.  cAMP promotes pancreatic beta-cell survival via CREB-mediated induction of IRS2. , 2003, Genes & development.

[39]  T. Hunter,et al.  The Protein Kinase Complement of the Human Genome , 2002, Science.

[40]  R. Nusse,et al.  Ablation of Insulin-Producing Neurons in Flies: Growth and Diabetic Phenotypes , 2002, Science.

[41]  C. Bogardus,et al.  The natural history of insulin secretory dysfunction and insulin resistance in the pathogenesis of type 2 diabetes mellitus. , 1999, The Journal of clinical investigation.

[42]  M. Okamoto,et al.  Cloning of a novel kinase (SIK) of the SNF1/AMPK family from high salt diet‐treated rat adrenal1 , 1999, FEBS letters.

[43]  L. Tsai,et al.  p35, the Neuronal-specific Activator of Cyclin-dependent Kinase 5 (Cdk5) Is Degraded by the Ubiquitin-Proteasome Pathway* , 1998, The Journal of Biological Chemistry.

[44]  M. Byrne,et al.  Elevated plasma glucose 2 h postchallenge predicts defects in beta-cell function. , 1996, The American journal of physiology.

[45]  O. Ohara,et al.  A novel RING-H2 motif protein downregulated by axotomy: its characteristic localization at the postsynaptic density of axosomatic synapse , 1995, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[46]  C. Newgard,et al.  Metabolic coupling factors in pancreatic beta-cell signal transduction. , 1995, Annual review of biochemistry.

[47]  M. Maffei,et al.  Positional cloning of the mouse obese gene and its human homologue , 1995, Nature.

[48]  M. Maffei,et al.  Positional cloning of the mouse obese gene and its human homologue , 1994, Nature.

[49]  R. Aebersold,et al.  A brain-specific activator of cyclin-dependent kinase 5 , 1994, Nature.

[50]  L. Tsai,et al.  p35 is a neural-specific regulatory subunit of cyclin-dependent kinase 5 , 1994, Nature.

[51]  J. Habener,et al.  Signal transduction crosstalk in the endocrine system: pancreatic beta-cells and the glucose competence concept. , 1992, Trends in biochemical sciences.

[52]  D. Kelley,et al.  Role of reduced suppression of glucose production and diminished early insulin release in impaired glucose tolerance. , 1992, The New England journal of medicine.

[53]  K. Polonsky,et al.  Abnormal patterns of insulin secretion in non-insulin-dependent diabetes mellitus. , 1988, The New England journal of medicine.

[54]  S. O’Rahilly,et al.  Impaired pulsatile secretion of insulin in relatives of patients with non-insulin-dependent diabetes. , 1988, The New England journal of medicine.